RIBOMIC Announces Positive Interim Results from Phase IIa Trial of umedaptanib pegol in Achondroplasia Demonstrating Increase in Annualized Growth Rate of up to 4.6 cmyear in Children 5 Years of Age and Older in the Low Dose Cohort
| SSDCX Fund | USD 26.56 0.07 0.26% |
Slightly above 54% of Deutsche Small's investor base is interested to short. The analysis of overall sentiment of trading Deutsche Small Cap mutual fund suggests that many investors are impartial at this time. Deutsche Small's investing sentiment can be driven by a variety of factors including economic data, Deutsche Small's earnings reports, geopolitical events, and overall market trends.
Deutsche |
TOKYO, November 05, 2024--RIBOMIC, Inc. , a clinical-stage pharmaceutical company specializing in aptamer therapeutics, has been conducting a Phase IIa clinical trial of umedaptanib pegol in pediatric patients with achondroplasia , and today announces that the administration of the low-dose subcutaneous injection group has been completed and demonstrated a positive impact of the test drug on the pati
Read at finance.yahoo.com
 |
Deutsche Small Fundamental Analysis
We analyze Deutsche Small's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deutsche Small using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deutsche Small based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
Deutsche Small is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
Deutsche Small Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deutsche Small mutual fund to make a market-neutral strategy. Peer analysis of Deutsche Small could also be used in its relative valuation, which is a method of valuing Deutsche Small by comparing valuation metrics with similar companies.
Peers
Deutsche Small Related Equities
| KTCCX | Deutsche Science | 0.75 | ||||
| KTCSX | Deutsche Science | 0.71 | ||||
| KTCIX | Deutsche Science | 0.70 | ||||
| KTCAX | Deutsche Science | 0.69 | ||||
| GCGGX | Deutsche Gnma | 0.34 | ||||
| SRMAX | Deutsche Short-term | 0.10 | ||||
| SRMCX | Deutsche Short-term | 0.10 |
Other Information on Investing in Deutsche Mutual Fund
Deutsche Small financial ratios help investors to determine whether Deutsche Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deutsche with respect to the benefits of owning Deutsche Small security.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |